Effect of the G72 (DAOA) putative risk haplotype on cognitive functions in healthy subjects

BMC Psychiatry

Volumn 9, Issue , 2009, Pages 60-

  Jansen, Andreas ^a   Krach, Sören ^a   Krug, Axel ^a   Markov, Valentin ^b   Eggermann, Thomas ^b   Zerres, Klaus ^b   Thimm, Markus ^a,b   Nöthen, Markus M ^c   Treutlein, Jens ^d   Rietschel, Marcella ^d   Kircher, Tilo ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d Central Institute of Mental Health   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; DEXTRO AMINO ACID OXIDASE; METHIONINE; PROTEIN G72; THYMINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATTENTION; BRAIN FUNCTION; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HIGH RISK POPULATION; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; INDIVIDUALITY; MALE; MENTAL FUNCTION; MOLECULAR PHYLOGENY; NORMAL HUMAN; SINGLE NUCLEOTIDE POLYMORPHISM; SPATIAL MEMORY; VERBAL MEMORY; WORKING MEMORY;

ADOLESCENT; ADULT; ALLELES; BRAIN; CARRIER PROTEINS; COGNITION; COGNITION DISORDERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 70449347585     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-9-60     Document Type: Article

References (45)

1. Glahn DC, Almasy L, Blangero J, Burk GM, Estrada J, Peralta JM, Meyenberg N, Castro MP, Barrett J, Nicolini H, Raventos H, Escamilla MA. Adjudicating neurocognitive endophenotypes for schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2007, 144B:242-249. 10.1002/ajmg.b.30446, 17034022.
2. Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 1998, 12:426-445. 10.1037/0894-4105.12.3.426, 9673998.
3. Quraishi S, Frangou S. Neuropsychology of bipolar disorder: a review. J Affect Disord 2002, 72:209-226. 10.1016/S0165-0327(02)00091-5, 12450638.
4. Tiihonen J, Haukka J, Henriksson M, Cannon M, Kieseppa T, Laaksonen I, Sinivuo J, Lonnqvist J. Premorbid intellectual functioning in bipolar disorder and schizophrenia: results from a cohort study of male conscripts. Am J Psychiatry 2005, 162:1904-1910. 10.1176/appi.ajp.162.10.1904, 16199837.
5. Zakzanis KK, Leach L, Kaplan E. On the nature and pattern of neurocognitive function in major depressive disorder. Neuropsychiatry Neuropsychol Behav Neurol 1998, 11:111-119.
6. Reichenberg A, Weiser M, Rabinowitz J, Caspi A, Schmeidler J, Mark M, Kaplan Z, Davidson M. A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder. Am J Psychiatry 2002, 159:2027-2035. 10.1176/appi.ajp.159.12.2027, 12450952.
7. Simon AE, Cattapan-Ludewig K, Zmilacher S, Arbach D, Gruber K, Dvorsky DN, Roth B, Isler E, Zimmer A, Umbricht D. Cognitive functioning in the schizophrenia prodrome. Schizophr Bull 2007, 33:761-771. 10.1093/schbul/sbm018, 2526133, 17412711.
8. Barrantes-Vidal N, Aguilera M, Campanera S, Fatjo-Vilas M, Guitart M, Miret S, Valero S, Fananas L. Working memory in siblings of schizophrenia patients. Schizophr Res 2007, 95:70-75. 10.1016/j.schres.2007.06.020, 17628433.
9. Ma X, Wang Q, Sham PC, Liu X, Rabe-Hesketh S, Sun X, Hu J, Meng H, Chen W, Chen EY, Deng W, Chan RC, Murray RM, Collier DA, Li T. Neurocognitive deficits in first-episode schizophrenic patients and their first-degree relatives. Am J Med Genet B Neuropsychiatr Genet 2007, 144B:407-416. 10.1002/ajmg.b.30330, 17440937.
10. Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005, 10:40-68. 10.1038/sj.mp.4001558, 15263907.
11. Owen MJ, Craddock N. O'Donovan MC, Schizophrenia: genes at last?. Trends Genet 2005, 21:518-525. 10.1016/j.tig.2005.06.011, 16009449.
12. Smoller JW, Gardner-Schuster E. Genetics of bipolar disorder. Curr Psychiatry Rep 2007, 9:504-511. 10.1007/s11920-007-0069-8, 18221632.
13. Chubb JE, Bradshaw NJ, Soares DC, Porteous DJ, Millar JK. The DISC locus in psychiatric illness. Mol Psychiatry 2008, 13:36-64. 10.1038/sj.mp.4002106, 17912248.
14. Detera-Wadleigh SD, McMahon FJ. G72/G30 in schizophrenia and bipolar disorder: review and meta-analysis. Biol Psychiatry 2006, 60:106-114. 10.1016/j.biopsych.2006.01.019, 16581030.
15. Craddock N, O'Donovan MC, Owen MJ. The genetics of schizophrenia and bipolar disorder: dissecting psychosis. J Med Genet 2005, 42:193-204. 10.1136/jmg.2005.030718, 1736023, 15744031.
16. Craddock N, O'Donovan MC, Owen MJ. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr Bull 2006, 32:9-16. 10.1093/schbul/sbj033, 2632175, 16319375.
17. Craddock N, Owen MJ. The beginning of the end for the Kraepelinian dichotomy. Br J Psychiatry 2005, 186:364-366. 10.1192/bjp.186.5.364, 15863738.
18. Green EK, Raybould R, Macgregor S, Gordon-Smith K, Heron J, Hyde S, Grozeva D, Hamshere M, Williams N, Owen MJ, O'Donovan MC, Jones L, Jones I, Kirov G, Craddock N. Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder. Arch Gen Psychiatry 2005, 62:642-648. 10.1001/archpsyc.62.6.642, 15939841.
19. Williams NM, Green EK, Macgregor S, Dwyer S, Norton N, Williams H, Raybould R, Grozeva D, Hamshere M, Zammit S, Jones L, Cardno A, Kirov G, Jones I, O'Donovan MC, Owen MJ, Craddock N. Variation at the DAOA/G30 locus influences susceptibility to major mood episodes but not psychosis in schizophrenia and bipolar disorder. Arch Gen Psychiatry 2006, 63:366-373. 10.1001/archpsyc.63.4.366, 16585465.
20. Maier W, Hofgen B, Zobel A, Rietschel M. Genetic models of schizophrenia and bipolar disorder: overlapping inheritance or discrete genotypes?. Eur Arch Psychiatry Clin Neurosci 2005, 255:159-166. 10.1007/s00406-005-0583-9, 15995899.
21. Rietschel M, Beckmann L, Strohmaier J, Georgi A, Karpushova A, Schirmbeck F, Boesshenz KV, Schmal C, Burger C, Jamra RA, Schumacher J, Hofels S, Kumsta R, Entringer S, Krug A, Markov V, Maier W, Propping P, Wust S, Kircher T, Nothen MM, Cichon S, Schulze TG. G72 and Its Association With Major Depression and Neuroticism in Large Population-Based Groups From Germany. Am J Psychiatry 2008, 165:753-762. 10.1176/appi.ajp.2008.07060883, 18346999.
22. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 2001, 98:6917-6922. 10.1073/pnas.111134598, 34453, 11381111.
23. Krug A, Markov V, Leube D, Zerres K, Eggermann T, Nothen MM, Skowronek MH, Rietschel M, Kircher T. Genetic variation in the schizophrenia-risk gene neuregulin1 correlates with personality traits in healthy individuals. Eur Psychiatry 2008, 23:344-349. 10.1016/j.eurpsy.2008.03.004, 18455369.
24. Sheldrick A, Krug A, Markov V, Leube D, Michel TM, Zerres K, Eggermann T, Kircher T. Effect of COMT val158 met Genotype on Cognition and Personality. Eur Psychiatry 2008, 23:385-389. 10.1016/j.eurpsy.2008.05.002, 18755576.
25. Jansen A, Krach S, Krug A, Markov V, Eggermann T, Zerres K, Stocker T, Shah NJ. Nothen MM, Treutlein J, Rietschel M, Kircher T, A putative high-risk haplotype of the G72 gene is associated with better performance in working memory functions in healthy individuals: A combined neuropsychological and functional imaging study. Neuroimage 2009, 45:1002-1008. 10.1016/j.neuroimage.2008.12.054, 19167508.
26. Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971, 9:97-113. 10.1016/0028-3932(71)90067-4, 5146491.
27. Shi J, Badner JA, Gershon ES, Liu C. Allelic association of G72/G30 with schizophrenia and bipolar disorder: a comprehensive meta-analysis. Schizophr Res 2008, 98:89-97. 10.1016/j.schres.2007.10.004, 2237895, 18023149.
28. Li D, He L. G72/G30 genes and schizophrenia: a systematic meta-analysis of association studies. Genetics 2007, 175:917-922. 10.1534/genetics.106.061796, 1800627, 17179078.
29. Abou JR, Schmael C, Cichon S, Rietschel M, Schumacher J, Nothen MM. The G72/G30 gene locus in psychiatric disorders: a challenge to diagnostic boundaries?. Schizophr Bull 2006, 32:599-608. 10.1093/schbul/sbl028, 2632259, 16914640.
30. Wechsler D. Wechsler Memory Scale: Administration and Scoring Manual. 1997, The Psychological Corporation: Harcourt Brace & Co, San Antonio TX.
31. Gold JM, Carpenter C, Randolph C, Goldberg TE, Weinberger DR. Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Arch Gen Psychiatry 1997, 54:159-165.
32. Reitan RM, Wolfson D. The Halstead-Reitan neuropsychological test battery: Theory and clinical interpretation. 1985, Neuropsychology Press, Tuscon.
33. Lezak M. Neuropsychological Assessment. 1995, Oxford University Press, Oxford.
34. Brickenkamp R. Der Aufmerksamkeits-Belastungstest d2. 2002, Hogrefe, Göttingen.
35. Goldberg TE, Straub RE, Callicott JH, Hariri A, Mattay VS, Bigelow L, Coppola R, Egan MF, Weinberger DR. The G72/G30 gene complex and cognitive abnormalities in schizophrenia. Neuropsychopharmacology 2006, 31:2022-2032. 10.1038/sj.npp.1301049, 16554747.
36. Opgen-Rhine C, Lencz T, Burdick KE, Neuhaus AH, DeRosse P, Goldberg TE, Malhotra AK. Genetic variation in the DAOA gene complex: Impact on susceptibility for schizophrenia and on cognitive performance. Schizophr Res 2008, 103:169-177. 10.1016/j.schres.2008.04.020, 2605318, 18541412.
37. Donohue G, Morris DW, Robertson IH, McGhee KA, Murphy K, Kenny N, Clarke S, Gill M, Corvin AP. DAOA ARG30LYS and verbal memory function in schizophrenia. Mol Psychiatry 2007, 0:1-2.
38. Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M, Abderrahim H, Bougueleret L, Barry C, Tanaka H, La RP, Puech A, Tahri N, Cohen-Akenine A, Delabrosse S, Lissarrague S, Picard FP, Maurice K, Essioux L, Millasseau P, Grel P, Debailleul V, Simon AM, Caterina D, Dufaure I, Malekzadeh K, Belova M, Luan JJ, Bouillot M, Sambucy JL, Primas G, Saumier M, Boubkiri N, Martin-Saumier S, Nasroune M, Peixoto H, Delaye A, Pinchot V, Bastucci M, Guillou S, Chevillon M, Sainz-Fuertes R, Meguenni S, urich-Costa J, Cherif D, Gimalac A, Van DC, Gauvreau D, Ouellette G, Fortier I, Raelson J, Sherbatich T, Riazanskaia N, Rogaev E, Raeymaekers P, Aerssens J, Konings F, Luyten W, Macciardi F, Sham PC, Straub RE, Weinberger DR, Cohen N, Cohen D. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA 2002, 99:13675-13680. 10.1073/pnas.182412499, 129739, 12364586.
39. Ohi K, Hashimoto R, Yasuda Y, Yoshida T, Takahashi T, Iike N, Fukumoto M, Takamura H, Iwase M, Kamino K, Ishii R, Kazui H, Sekiyama R, Kitamura Y, Azechi M, Ikezawa K, Kurimoto R, Kamagata E, Tanimukai H, Tagami S, Morihara T, Ogasawara M, Okochi M, Tokunaga H, Numata S, Ikeda M, Ohnuma T, Ueno S, Fukunaga T, Tanaka T, Kudo T, Arai H, Ohmori T, Iwata N, Ozaki N, Takeda M. Association study of the G72 gene with schizophrenia in a Japanese population: a multicenter study. Schizophr Res 2009, 109:80-85. 10.1016/j.schres.2009.01.019, 19237267.
40. Boks MP, Rietkerk T, Beek MH, Sommer IE, de Koning TJ, Kahn RS. Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophrenia. Eur Neuropsychopharmacol 2007, 7:567-572.
41. Coyle JT. Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol 2006, 26:365-384. 10.1007/s10571-006-9062-8, 16773445.
42. Kvajo M, Dhilla A, Swor DE, Karayiórgou M, Gogos JA. Evidence implicating the candidate schizophrenia/bipolar disorder susceptibility gene G72 in mitochondrail function. Mol Psychiatry 2008, 13:685-696. 10.1038/sj.mp.4002052, 17684499.
43. Hall J, Whalley HC, Moorhead TW, Baig BJ, McIntosh AM, Job DE, Owens DG, Lawrie SM, Johnstone EC. Genetic Variation in the DAOA (G72) Gene Modulates Hippocampal Function in Subjects at High Risk of Schizophrenia. Biol Psychiatry 2008, 64:428-433. 10.1016/j.biopsych.2008.03.009, 18423426.
44. Harrison PJ. The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology (Berl) 2004, 174:151-162. 10.1007/s00213-003-1761-y, 15205886.
45. Heckers S. Neuroimaging studies of the hippocampus in schizophrenia. Hippocampus 2001, 11:520-528. 10.1002/hipo.1068, 11732705.